1st Quarter - Termination
ARENTFOX SCHIFF LLP for CSL BEHRING
Firm
Client
Income
$10,000
Expenses
—
Terminated
Mar 31, 2019
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislation pertaining to orphan drugs Orphan drug tax exclusion in the Patient Protection and Affordable Care Act
Foreign entity interest: CSL Limited, identified in the LD-1, is interested in U.S. health care policies that may affect the business of its subsidiary CSL Behring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH | — |
| SONJA NESBIT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.